Wells Fargo & Company Zomedica Corp. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Zomedica Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 27,518 shares of ZOM stock, worth $3,577. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,518
Previous 36,945
25.52%
Holding current value
$3,577
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ZOM
# of Institutions
96Shares Held
84.1MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.3MShares$6.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.61MShares$1.25 Million0.0% of portfolio
-
State Street Corp Boston, MA3.51MShares$456,2840.0% of portfolio
-
Gsa Capital Partners LLP London, X03MShares$389,4630.03% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $127M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...